Chair of the Board: John Thomson.
John Thomson is the chief executive of a securities broking business in Edinburgh. He was educated as an economist at Strathclyde and then Oxford universities. At his graduation in 1972, he was
awarded the University of Strathclyde’s Economics Prize. Most of his career has been as an investment manager and then as a manager of investment businesses in the United Kingdom.
John began his career as an economist in Fiji and then Edinburgh, before entering the investment business in 1980 as an analyst with Scottish Investment Trust. He then went on to manage money at Standard Life, and helped build the company to become one of the most successful fund managers in the 1980s. During his fifteen years at Standard Life, John managed quoted equities in Japan, North America, the UK and Europe. During the 1990s he moved into senior management positions at Standard Life.
In 1997 he left Standard Life to become Managing Director of Stewart Ivory, a private client and fund management business based in Charlotte Square. After the company was sold to First State in 2000, John left and went on to set-up a hedge fund business and then joined RIA Capital Markets, where he was Executive Chairman until 2010. RIA is an agency broker that specialises in bond research and broking for institutional clients around the world.
Non- Executive Director: Malcolm Gillies.
Malcolm Gillies was a senior corporate finance partner in the UK commercial law firm, Shepherd+ Wedderburn. As a lawyer in private practice he had 35 years in depth, practical experience of corporate, commercial and international transactions, including periods based in the Middle East and in Brussels. Malcolm now has board appointments with several listed and private companies including Axis-Shield PLC, Trading Emissions PLC and Aircraft Medical Limited as well as voluntary positions with universities and charities.
CEO: Patricia Connolly.
Prof Connolly is a Chartered Engineer with extensive academic and medical industry experience in research, development and commercialisation. She founded the Bioelectronics Research Group at the University of Glasgow in 1988. From 1992 she was based in the medical industry as Head of Research, Byk Gulden Italia (Altana Pharma), Milan, Italy, 1992-1997 and then Technical Director, Nycomed Amersham, Lausanne, Switzerland 1997-1999 .
In 1999 she was appointed to a new Chair in Bioengineering at the University of Strathclyde where she has built a substantial portfolio of medical diagnostics research projects aimed at bringing new and less invasive diagnostic devices to the clinic and to community medicine.
From 2003-2007 she advised IVMD LTD as their Chief Science Officer, streamlining their research and development portfolio and four patents were filed from strategic projects pursued in that period. She has a strong interest in strategies for the successful commercialisation of medical device research and in 2006 she founded the Strathclyde Institute of Medical Devices to look after the University’s interests in this sector across the industrial and clinical interfaces. She has particular awareness of the regulatory needs of new medical products having registered new technology for the FDA and CE mark and has worked on industrialisation projects to take research prototypes from the laboratory to full production.
She is currently the recipient of grant funding in excess of £5m. She was elected a Fellow of the Institution of Electrical Engineers (now IET) in 2001, a Fellow of the Royal Society of Edinburgh
in 2006, a Fellow of the Royal Society of Medicine in 2007and a Fellow of the Royal Academy of Engineering in 2014.
She has previously worked with the Sales Director, John Hilferty, when he was Sales and Export Director in Nycomed Amersham and with the Technical Director, Nasser Djennati, in his role as Technical Director for IVMD Ltd.
Finance and Operations Director: Alistair MacWilliam.
Alistair MacWilliam has many years of experience in financial consultancy and shared services.
He was a director of Shell in the UK and a member of Shell's global Finance Operations Leadership team. In his UK role, he was responsible for Shell's financial shared services operations in Europe and was a member of the UK Chairman's Country Coordination Team. In his global role, he was a member of a leadership team that sets the direction for Shell's global Finance Operations.
He received a BSc in Engineering from Glasgow University in 1972. He then trained as a CA and in 1980 moved into management consultancy. He worked on major management consultancy assignments with Ernst & Young before joining Shell in 2000. He was the director and General Manager of Shell's Business centre in Glasgow from 2004-2009.
He was a Scottish CBI Council Member from 2005-2009 representing the interests of both the oil and shared services industries.
Sales Director: John Hilferty.
John Hilferty is a well-established Sales and Marketing professional who was with Amersham plc (now GE Healthcare) from 1987-2004 holding senior sales roles including Export Director. He has had direct sales and field force management responsibility for regions including Russia, South America and the Middle East in medical products. He developed sales and marketing strategies for new contrast media injectors for Amersham between 1998 and 2004 and in this role had direct experience of medical device sales and procurement issues. He has been employed by a major diagnostics distributor in Ireland in the past (Brennan) giving him direct experience of distributor’s issues. He has served on the UK Latin American Trade Advisory Group. He is currently Sales Director for Space (Cruise Ship and Yacht Design).
Technical Director: Nasser Djennati.
Dr Djennati is an engineer with both industrial and academic experience. For the past 8 years he has been Head of Research and Technical Director in IVMD Ltd leading a small team of scientists and engineers to design several novel Medical Point of Care devices which helped to attract business angels and VCs to the company. He has filed several patents in Medical and POC devices and has been involved in project management of complex projects designed to meet crucial timescales involving multi-disciplinary teams, and on an international scale. He has developed a new blood coagulation point of care instrument for a major medical client and supported (successful) clinical trials of the instrument in the UK and overseas.
He has experience of working with academic partners from his time as a senior engineer at UMIST (1990-1993) and from ongoing collaborative projects during his time with IVMD.